Zymergi LogoCart

483 Document: OMRIX Biopharmaceuticals LTD, Feb 24, 2020

FDANews 483 OMRIX Biopharmaceuticals LTD Feb 24 2020 top
Steven E. Bowen FDA Investigator Chava Kimchi Sarfaty FDA Investigator Mihaly S. Ligmond FDA Investigator Kimchi Sarfaty, Chava FDA Investigator

On Feb 24, 2020, the FDA inspected OMRIX Biopharmaceuticals LTD's Ramat Gan site. Explore the inspectional observations.